Literature DB >> 2945555

Effect of an anti-insulin-like growth factor I receptor antibody on insulin-like growth factor II stimulation of DNA synthesis in human fibroblasts.

C A Conover, P Misra, R L Hintz, R G Rosenfeld.   

Abstract

To investigate the role of insulin-like growth factor II in the control of DNA synthesis in human fibroblasts, dose-response curves for insulin-like growth factor I and II stimulation of [3H]thymidine incorporation were compared in the absence and presence of alpha IR-3, a highly specific monoclonal antibody directed against the type I insulin-like growth factor receptor. Specific binding of [125I]insulin-like growth factor I to human fibroblast monolayer cultures was inhibited 60-70% in the presence of alpha IR-3. alpha IR-3 had no effect on [125I]insulin-like growth factor II binding to human fibroblasts. However, alpha IR-3 inhibited both insulin-like growth factor I and II stimulated [3H]thymidine incorporation. These data indicate that the type II insulin-like growth factor receptor does not function as a transducer of insulin-like growth factor II's mitogenic effect in human fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2945555     DOI: 10.1016/s0006-291x(86)80019-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Authors:  M Kaleko; W J Rutter; A D Miller
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

Review 2.  From animal to molecule: aspects of the biology of insulin-like growth factors.

Authors:  R S Gilmour; C G Prosser; I R Fleet; L Cocco; J C Saunders; K D Brown; A N Corps
Journal:  Br J Cancer Suppl       Date:  1988-12

3.  Ligand-receptor interactions involved in the stimulation of Swiss 3T3 fibroblasts by insulin-like growth factors and insulin.

Authors:  A N Corps; K D Brown
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

Review 4.  Biology of the somatotroph axis (after the pituitary).

Authors:  Ron G Rosenfeld; Vivian Hwa
Journal:  Ann Endocrinol (Paris)       Date:  2017-05-08       Impact factor: 2.478

5.  A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts.

Authors:  C A Conover
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

6.  Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.

Authors:  D N Shapiro; B G Jones; L H Shapiro; P Dias; P J Houghton
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

7.  Presence of insulinlike growth factor receptors and lack of insulin receptors on fetal bovine smooth muscle cells.

Authors:  P D Lee; R L Hintz; R G Rosenfeld; W E Benitz
Journal:  In Vitro Cell Dev Biol       Date:  1988-09

8.  The receptor for insulin-like growth factor II mediates an insulin-like response.

Authors:  J Hari; S B Pierce; D O Morgan; V Sara; M C Smith; R A Roth
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

9.  Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer.

Authors:  V M Macauly; J D Teale; M J Everard; G P Joshi; I E Smith; J L Millar
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.